OR WAIT null SECS
© 2021 MJH Life Sciences and Consultant Live. All rights reserved.
The HCPLive rheumatoid arthritis page is a comprehensive resource for clinical news and insights on arthritis. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for RA, and more.
October 14, 2021
During this video interview, Dr. Jay Mehta talks about his approach to explaining such complex medical conditions and treatments to his pediatric patients and their families.
October 11, 2021
Dr. Mehta talks about rheumatologic testing, joint examinations, and the great relationships he gets to develop with his patients.
October 09, 2021
Dr. Mehta highlights some of the challenges that come with treating pediatric rheumatology patients and how he handles them.
October 08, 2021
In this video interview, Dr. Jay Mehta discusses his presentation on pediatric rheumatology for the American Association of Pediatrics Conference.
October 07, 2021
The 2 studies focused on upadacitinib treatment for one group of patients with ankylosing spondylitis and another group of patients with non-radiographic axial spondyloarthritis.
September 28, 2021
Looking specifically at patients who have been treated with biologic disease-modifying anti-rheumatic drugs, this study examines the risk of new or recurrent cancer.
September 09, 2021
Investigators analyze the differences between SARS-CoV-2 testing and risk of infection.
August 31, 2021
Investigators found no significant differences in the efficacy and safety of the originator or biosimilars in children with juvenile idiopathic arthritis.
August 20, 2021
Investigators gathered data from vulnerable populations with rheumatic disease regarding their thoughts and opinions on the COVID-19 virus.
August 11, 2021
Dr. Blauvelt speaks on the results of the phase 3b Heads Up study, and the future of upadacitinib and dupilumab in atopic dermatitis management.